Age | 1.74 | 1.026 | 0.956–1.096 | 0.1476 | | | | |
Sex | 0.53 | 0.837 | 0.505–1.333 | 0.4647 | | | | |
NYHA functional class | 35.2 | 2.121 | 1.669–2.730 | <0.001 | 7.75 | 1.423 | 1.121–1.827 | 0.0054 |
Systolic blood pressure | 0.32 | 0.988 | 0.503–1.430 | 0.6154 | | | | |
Diastolic blood pressure | 0.45 | 0.972 | 0.517–1.381 | 0.5401 | | | | |
Heart rate | 0.88 | 0.993 | 0.979–1.006 | 0.3473 | | | | |
Diabetes mellitus | 3.24 | 1.536 | 0.962–2.388 | 0.0716 | | | | |
Hypertension | 0.005 | 0.982 | 0.603–1.547 | 0.9416 | | | | |
Dyslipidemia | 17.2 | 0.263 | 0.172–0.529 | <0.001 | 5.67 | 0.397 | 0.163–0.851 | 0.0172 |
Atrial fibrillation | 0.55 | 0.827 | 0.484–1.345 | 0.4566 | | | | |
Ventricular tachycardia/ventricular fibrillation | 0.37 | 1.143 | 0.738–1.744 | 0.5412 | | | | |
lschemic heart disease | 2.86 | 1.475 | 0.940–2.279 | 0.1133 | | | | |
History of myocardial infarction | 0.002 | 0.976 | 0.563–1.569 | 0.9871 | | | | |
Washout ratio | 22.8 | 1.054 | 1.031–1.078 | <0.001 | 2.21 | 1.020 | 0.993–1.047 | 0.137 |
Early HMR | 17.0 | 0.311 | 0.163–0.562 | <0.001 | 0.37 | 0.725 | 0.256–1.928 | 0.5428 |
Late HMR | 40.0 | 0.127 | 0.062–0.251 | <0.001 | 6.18 | 0.215 | 0.064–0.718 | 0.0129 |
Diuretics | 12.1 | 2.723 | 1.521–5.189 | 0.001 | 1.53 | 1.482 | 0.795–2.929 | 0.2164 |
Angiotensin-converting enzyme inhibitors | 0.11 | 0.906 | 0.501–1.582 | 0.7662 | | | | |
Angiotensin-receptor blockers | 0.001 | 0.998 | 0.625–1.557 | 0.996 | | | | |
Calcium channel blockers | 0.25 | 1.142 | 0.660–1.873 | 0.6196 | | | | |
β-blockers | 0.35 | 0.845 | 0.455–1.514 | 0.5845 | | | | |
Nitrates | 19.9 | 3.182 | 1.935–5.246 | <0.001 | 3.98 | 1.699 | 1.016–2.813 | 0.0461 |
Nicorangil | 0.14 | 0.870 | 0.386–1.696 | 0.7044 | | | | |
Antiarrhythmic drugs | 1.29 | 0.783 | 0.510–1.192 | 0.256 | | | | |
Antiplatelet agent | 0.07 | 0.942 | 0.615–1.468 | 0.7884 | | | | |
Anticoagulation agent | 2.48 | 1.414 | 0.918–2.171 | 0.155 | | | | |
Statins | 9.35 | 0.391 | 0.198–0.732 | 0.002 | 3.26 | 0.526 | 0.225–1.057 | 0.071 |
BNP concentration (n = 267) | 14.1 | 1.000 | 1.000–1.001 | 0.0002 | | | | |
Hemoglobin level | 92.5 | 0.702 | 0.649–0.810 | <0.001 | 7.48 | 0.821 | 0.708–0.946 | 0.0062 |
Estimated GFR | 16.1 | 0.977 | 0.963–0.985 | <0.001 | 5.08 | 0.984 | 0.970–0.998 | 0.0243 |
Left ventricular ejection fraction | 0.28 | 0.960 | 0.509–1.481 | 0.6532 | | | | |
End-diastolic left ventricular diameter | 2.07 | 1.016 | 0.994–1.038 | 0.1403 | | | | |
End-systolic left ventricular diameter | 0.93 | 1.012 | 0.987–1.038 | 0.3344 | | | | |
End-diastolic interventricular septal wall thickness | 0.46 | 0.971 | 0.891–1.052 | 0.4963 | | | | |
End-diastolic posterior wall thickness | 0.17 | 0.979 | 0.884–1.077 | 0.6801 | | | | |
Left atrial diameter | 0.59 | 1.050 | 0.827–1.355 | 0.3813 | | | | |